However, the preponderance of studies analyzing the role of CD28 and/or its ligands CD80/86 in models in which the recipients used are immunologically naïve have demonstrated that deleting or antagonizing CD28 signaling results in improved sepsis mortality. This evidence concerns the gene CD28 and Sepsis.